When PD-L1 expression analyses were restricted to only tumor cells, there was no statistically significant increase in the probability of response for patients with positive (≥ 1%) versus negative (< 1%) tumors (P = .348, one-sided test). This evidence concerns the gene CD274 and neoplasm.